These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 20807816)

  • 21. Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics.
    Tyagi N; Arora S; Deshmukh SK; Singh S; Marimuthu S; Singh AP
    J Biomed Nanotechnol; 2016 Jan; 12(1):28-42. PubMed ID: 27301170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of microRNA therapeutics is coming of age.
    van Rooij E; Kauppinen S
    EMBO Mol Med; 2014 Jul; 6(7):851-64. PubMed ID: 24935956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).
    Gambari R; Brognara E; Spandidos DA; Fabbri E
    Int J Oncol; 2016 Jul; 49(1):5-32. PubMed ID: 27175518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications.
    Brown BD; Naldini L
    Nat Rev Genet; 2009 Aug; 10(8):578-85. PubMed ID: 19609263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment.
    Moles R
    Microrna; 2017 Aug; 6(2):102-109. PubMed ID: 28699479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNAi in clinical studies.
    Kubowicz P; Żelaszczyk D; Pękala E
    Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoscale delivery systems for microRNAs in cancer therapy.
    Boca S; Gulei D; Zimta AA; Onaciu A; Magdo L; Tigu AB; Ionescu C; Irimie A; Buiga R; Berindan-Neagoe I
    Cell Mol Life Sci; 2020 Mar; 77(6):1059-1086. PubMed ID: 31637450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micromanipulating cancer: microRNA-based therapeutics?
    Petrocca F; Lieberman J
    RNA Biol; 2009; 6(3):335-40. PubMed ID: 19535911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.
    Awasthi R; Rathbone MJ; Hansbro PM; Bebawy M; Dua K
    Drug Deliv Transl Res; 2018 Feb; 8(1):97-110. PubMed ID: 29185148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies.
    Seo HA; Moeng S; Sim S; Kuh HJ; Choi SY; Park JK
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers.
    Dai X; Tan C
    Adv Drug Deliv Rev; 2015 Jan; 81():184-97. PubMed ID: 25281917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.
    Ibrahim AF; Weirauch U; Thomas M; Grünweller A; Hartmann RK; Aigner A
    Cancer Res; 2011 Aug; 71(15):5214-24. PubMed ID: 21690566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of microRNAs in COVID-19 with implications for therapeutics.
    Arghiani N; Nissan T; Matin MM
    Biomed Pharmacother; 2021 Dec; 144():112247. PubMed ID: 34601190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA therapeutics: principles, expectations, and challenges.
    Rupaimoole R; Han HD; Lopez-Berestein G; Sood AK
    Chin J Cancer; 2011 Jun; 30(6):368-70. PubMed ID: 21627858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA-101: a potential target for tumor therapy.
    Gui T; Shen K
    Cancer Epidemiol; 2012 Dec; 36(6):537-40. PubMed ID: 22647681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progresses in microRNA Delivery Using Synthetic Nanovectors in Cancer Therapy.
    Javanmardi S; Aghamaali MR; Abolmaali SS; Tamaddon AM
    Curr Pharm Des; 2018; 24(31):3678-3696. PubMed ID: 30465494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.